Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1855 participants
OBSERVATIONAL
2008-03-31
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to determine whether the Combined-Apgar predicts poor outcome better than the Specified- or Expanded Apgar alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial to Evaluate a Specified Type of Apgar (TEST-APGAR) Follow Up Study
NCT01186627
Apgar-Score in Asphyxiated Infants Under Resuscitation
NCT01193751
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
NCT06961123
Neonatal Pulse Oximetry Compared With Apgar Scores
NCT01223573
Video Recording in the Delivery Room in Very Preterm Infants (Video Apgar Trial)
NCT01420107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To validate the accuracy of these scores in a population of very preterm infants, the present prospective, observational, international multicenter study is planned. Until today there is no gold standard available to describe infant's conditions and interventions. For the evaluation of the scores it was therefore hypothesized that the Combined Apgar predicts poor outcome (defined as either death or any major morbidity) better than the Specified Apgar or Expanded Apgar alone. Prediction of poor outcome was used as a surrogate parameter to test the predictive value of the Combined-Apgar score in a clinical setting for preterm infants. In an attempt to determine how strong of an association there is between the Combined Apgar Score and neurologic impairment in early childhood, we are presently engaged in a long-term follow-up of all surviving infants at a corrected age of 24 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* born within the study centres
Exclusion Criteria
* outborn
* major congenital abnormalities
* death in the delivery room
1 Minute
10 Minutes
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dresden University of Technology, Department for Neonatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mario Ruediger
Role: PRINCIPAL_INVESTIGATOR
Department of Neonatology and Pediatric Intensive Care, University Hospital Carl Gustav Carus Dresden, Germany
Helmut Kuester
Role: PRINCIPAL_INVESTIGATOR
Department of Neonatology and Pediatric Intensiv Care, Ernst-Moritz-Arndt-University Greifswald, Germany
References
Explore related publications, articles, or registry entries linked to this study.
Mense L, Nogel S, Kaufmann M, Kuster H, Braun N, Simma B, Rudiger M. Assessing the postnatal condition: the predictive value of single items of the Apgar score. BMC Pediatr. 2025 Mar 19;25(1):214. doi: 10.1186/s12887-025-05565-0.
Rudiger M, Braun N, Aranda J, Aguar M, Bergert R, Bystricka A, Dimitriou G, El-Atawi K, Ifflaender S, Jung P, Matasova K, Ojinaga V, Petruskeviciene Z, Roll C, Schwindt J, Simma B, Staal N, Valencia G, Vasconcellos MG, Veinla M, Vento M, Weber B, Wendt A, Yigit S, Zotter H, Kuster H; TEST-Apgar Study-Group. Neonatal assessment in the delivery room--Trial to Evaluate a Specified Type of Apgar (TEST-Apgar). BMC Pediatr. 2015 Mar 8;15:18. doi: 10.1186/s12887-015-0334-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEST-APGAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.